Analysis of reasons for the late diagnosis of amylotrophic lateral sclerosis;Étude des causes du retard au diagnostic de la sclérose latérale amyotrophique

Revue Neurologique

Volumn 162, Issue 5, 2006, Pages 617-622

  Torny, F ^a   Lacoste, M ^a   Nguyen, J M ^b   Tymoczko Nguyen, M E ^a   Couratier, P ^a,c,d  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF LIMOGES   (France)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Amyotrophic lateral sclerosis; Diagnostic delay; Medical education

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; CONSULTATION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE COURSE; ELECTROPHYSIOLOGY; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL SCHOOL; OBSERVATIONAL STUDY; PATIENT CARE; PATIENT REFERRAL; PRIVATE PRACTICE; CLINICAL COMPETENCE; DIFFERENTIAL DIAGNOSIS; FRANCE; GENERAL PRACTICE; INFORMATION PROCESSING; MEDICINE; MIDDLE AGED; MOTOR NEURON DISEASE; NEUROLOGIC EXAMINATION; PROGNOSIS; PSYCHOLOGICAL ASPECT; RISK FACTOR; TIME;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL COMPETENCE; DATA COLLECTION; DIAGNOSIS, DIFFERENTIAL; FAMILY PRACTICE; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NEUROLOGIC EXAMINATION; PATIENT CARE TEAM; PROGNOSIS; REFERRAL AND CONSULTATION; RISK FACTORS; SPECIALTIES, MEDICAL; TIME FACTORS;

EID: 33646727596     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(06)75055-X     Document Type: Article

References (21)

1. ABOUSSOUAN LS, KHAN SU, BANERJEE M, ARROLIGA AC, MITSUMOTO H. (2001). Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve, 24: 403-409.
2. BENSIMON G, LACOMBLEZ L, MEININGER V, AND THE ALS/RILUZOLE STUDY GROUP. (1994). A controlled Trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med, 330: 585-591.
3. BROOKS BR. (1994). El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis: Subcomitee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group in Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributions. J Neurol Sci, 124: S96-S107.
4. BROOKS BR. (1999a). Earlier is better: the benefits of early diagnosis. Neurology, 53(Suppl 5): S53-S54.
5. BROOKS BR. (1999b). What are the implications of early diagnosis? Maintaining optimal health as long as possible. Neurology, 53(Suppl 5): S43-S45.
6. CHIO A. (1999). ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol, 246: III1-5.
7. COURATIER P, DESPORT JC, ANTONINI MT, MABROUK T, PERNA A, VINCENT F, MELLONI B. (2004). Prise en charge nutritionnelle et respiratoire des patients atteints de Sclérose latérale amyotrophique. Rev Neurol (Paris), 160: 243-250.
8. COURATIER P, DRUET-CABANAC M, TRUONG CT, BERNET-BERNADY P, DUMAS M, VALLAT JM, PREUX PM. (2000). Intérêts d'une base de données informatisées dans le diagnostic et le suivi de patients atteints de sclérose latérale amyotrophique. Rev Neurol (Paris), 156: 357-363.
9. DENGLER R. (1999). Current treatment pathways in ALS: an European perspective. Neurology, 53: S4-S10.
10. FORBES RB, COLVILLE S, CRAN GW, SWINGLER RJ; SCOTTISH MOTOR NEURONE DISEASE REGISTER. (2004). Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry, 75: 1753-1755.
11. GELINAS DF, O'CONNOR P, MILLER RG. (1998). Quality of life for ventilator-dependent ALS patients and their caregivers. J Neurol Sci, 160 (Suppl 1): S134-S136.
12. GELINAS D. (1999). Conceptual approach to diagnosis delay in ALS: a Unites States perspective. Neurology, 53: S17-S19.
13. LACOMBLEZ L. BENSIMON G, LEIGH PN, GUILLET P, MEININGER V. (1996). Dose-ranging study of riluzole in amytrophic lateral sclerosis. Lancet, 347: 1425-1431.
14. LI T, ALBERMAN E, SWASH M. (1990). Clinical features associations of 560 cases of motor neuron disease. J Neurosurg Psychiatry, 53: 1043-1045.
15. LYALL RA, DONALDSON N, FLEMING T et al. (2001). A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology, 57: 153-156.
16. MAZZINI L, CORRA T, ZACCALA M, MORA G, DEL PIANO M, GALANTE M. (1995). Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol, 242: 695-698.
17. MILLER RG, MUNSAT TL, SWASH M, BROOKS BR FOR THE WORLD FEDERATION OF NEUROLOGY COMMITTEE ON RESEARCH. (1999). Consensus guidelines for the design and implementation of clinical trials in ALS. J Neurol Sci, 169: 2-12.
18. MILLUL A, BEGHI E, LOGROSCINO G, MICHELI A, VITELLI E, ZARDI A. (2005). Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology, 25: 114-119.
19. NORRIS F, SHEPHERD R, DENYS E et al. (1993). Onset, natural history and oucome in idiopathic adult motor neuron disease. J Neurol Sci, 118: 48-55.
20. RIVIÈRE M, MEININGER V, ZEISSER P, MUNSAT P. (1998). An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with Riluzole. Arch Neurol, 55: 526-528.
21. TESTA D, LOVATI R, FERRARINI M, SALMOIRAGHI F, FILIPPINI G. (2004). Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord, 5: 208-212.